Guardant Health, Inc. — Earnings Quality Grade F
GH · Healthcare
Major red flags
Screening Summary
Management Signals
Financial Trends
Revenue & Net Income ($B)
Margins (%)
18-Point Screening
Revenue Quality
DSO 49 days, change -3 days YoY
AR growth 24.1% vs revenue growth 32.9%
Revenue 32.9%, CFFO 23.0%. Cash follows revenue
Expense Quality
Inventory 20.8% vs COGS 20.4%. Normal
CapEx growth 37.7% vs revenue 32.9%. Normal
SG&A/Gross Profit = 111.5%, exceeds 70%
Gross margin 64.5%, change +3.7pp. Stable
Cash Flow Quality
CFFO < Net Income for 3 consecutive years
FCF is negative ($-0.2B)
Accruals ratio = -11.5%. Low accruals
Cash $1.2B covers 70% of debt $1.7B
Balance Sheet Health
Goodwill+Intangibles $0.1B = -104% of equity. Manageable
Interest coverage = -112.2x (<2x). Financial stress
Other assets -1.2% vs revenue 32.9%. Normal
No write-off data
Acquisition Risk
FCF after acquisitions negative for 3 years
Goodwill+Intangibles surged 927% YoY
Manipulation Score
M-Score = -2.71 (< -2.22). Unlikely manipulator
Portfolio monitoring
Monitor GH continuously
The full checks and model details are free to read. Use Watchlist to track your holdings; Pro adds automatic quarterly rescoring, risk-event email alerts, scans up to 50 tickers, and export workflows.
Beneish M-Score
Altman Z-Score
Generated from public financial data using forensic accounting frameworks. Not investment advice. Data: Yahoo Finance · 2026-04-25